Medullary Thyroid Carcinoma Surveillance Study: a Case-Series Registry (H9X-MC-B001)

Study identification

• EU PAS number:
  EUPAS45076
• Study ID:
  45077
• Official title and acronym:
  Medullary Thyroid Carcinoma Surveillance Study: a Case-Series Registry (H9X-MC-B001)
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study description:
  Please refer to EUPAS8759. This study is conducted in the US. ; The aim of the study is to monitor the number of annual new cases of medullary thyroid carcinoma (MTC) and to establish a registry of incident cases of MTC in adults in order to characterize their medical histories and possible risk factors, including history of treatment with long-acting GLP-1 receptor agonists.
• Study status:
  Ongoing

Research institutions and networks

Institutions

United BioSource Corporation (UBC)

Switzerland

Study timelines

Date when funding contract was signed

Actual:19/01/2015

Study start date

Actual:19/01/2015

Date of final study report

Planned:31/12/2030

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Eli Lilly and Company, Novo-Nordisk, AstraZeneca

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  EU RMP category 3 (required)